---
title: 'Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell
  lymphoma: EBMT Lymphoma Working Party study'
date: '2024-08-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39213423/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240831181359&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Although broadly employed, consolidative autologous hematopoietic stem
  cell transplantation (autoHCT) for relapsed/refractory (r/r) T-cell/histiocyte-rich
  large B-cell lymphoma (THRLBCL) has never been specifically investigated. Here we
  have analyzed outcomes of autoHCT for THRLBCL compared to diffuse large cell B-cell
  lymphoma not otherwise specified (DLBCL). Eligible for this retrospective registry
  study were adult patients with r/r THRLBCL and DLBCL, respectively, who underwent
  a ...
disable_comments: true
---
Although broadly employed, consolidative autologous hematopoietic stem cell transplantation (autoHCT) for relapsed/refractory (r/r) T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) has never been specifically investigated. Here we have analyzed outcomes of autoHCT for THRLBCL compared to diffuse large cell B-cell lymphoma not otherwise specified (DLBCL). Eligible for this retrospective registry study were adult patients with r/r THRLBCL and DLBCL, respectively, who underwent a ...